EcoDrugPlus

Cathepsin C

Ensembl ID : ENSXMAG00000027463
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSXMAG00000008976
Gene Symbol: LOC102230067
3 Cross references
222 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSXMAG00000003793
Gene Symbol: LOC102235885
2 Cross references
183 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSXMAG00000008983
Gene Symbol: LOC102230330
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSXMAG00000004158
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSXMAG00000010921
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSXMAG00000029164
Gene Symbol: CCR9A
1 Cross references
188 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSXMAG00000029692
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin Receptor Type A-Like

Ensembl ID : ENSXMAG00000022153
Gene Symbol: LOC102226360
2 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSXMAG00000025852
Gene Symbol: LOC102231199
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSXMAG00000010894
Gene Symbol: LOC102224087
3 Cross references
252 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSXMAG00000015730
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).